STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) Gross margin

Alert me on Gross margin

STERIS plc's gross margin over the twelve months to 30 June 2026 was 44.4%, up 0.2 percentage points from fiscal 2026 (44.3%). Over the past ten years it has ranged from 39.3% (fiscal 2017) to 44.6% (fiscal 2022); the current reading is higher than 92% of that period. That is below the Medical Devices industry median of 56.0% and below the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2026 44.3% 0.24
FY2025 44.0% 0.85
FY2024 43.2% (0.50)
FY2023 43.7% (0.93)
FY2022 44.6% 1.37
FY2021 43.2% (0.33)
FY2020 43.6% 1.32
FY2019 42.2% 0.52
FY2018 41.7% 2.43
FY2017 39.3% (0.72)

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 45.8% 1.95
Mar 2026 43.9% 0.08
Dec 2025 43.8% (0.42)
Sep 2025 44.2% (0.91)
42 more quarters

Against its own ten years

Low 39.3% High 44.6%
Ten-year median 43.2%
Current reading's percentile 90

Gross margin against peers

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on STE